November 5th 2024
Thomas Westbrook, MD, discusses the investigation of approved ccRCC treatments in patients with non-ccRCC.
October 25th 2024
Thomas Westbrook, MD, discusses the evolving understanding of non–clear cell renal cell carcinoma subtypes and implications for clinical practice.